Wells Fargo & Company Begins Coverage on Henry Schein (NASDAQ:HSIC)

Analysts at Wells Fargo & Company assumed coverage on shares of Henry Schein (NASDAQ:HSIC) in a research note issued to investors on Friday, Marketbeat reports. The brokerage set an “equal weight” rating and a $80.00 price target on the stock. Wells Fargo & Company‘s price objective would indicate a potential upside of 5.26% from the company’s previous close.

Other research analysts have also recently issued reports about the company. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Jefferies Financial Group lifted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Barrington Research lifted their price objective on Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a report on Thursday, January 30th. Finally, Mizuho began coverage on Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Eight analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $80.09.

Henry Schein Stock Down 2.1 %

Shares of HSIC stock opened at $76.00 on Friday. Henry Schein has a 12 month low of $63.67 and a 12 month high of $82.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market cap of $9.48 billion, a PE ratio of 31.28, a price-to-earnings-growth ratio of 2.21 and a beta of 0.91. The stock has a 50 day moving average of $74.01 and a 200-day moving average of $72.00.

Insider Activity at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.14% of the stock is currently owned by company insiders.

Institutional Trading of Henry Schein

Hedge funds and other institutional investors have recently modified their holdings of the stock. Clarkston Capital Partners LLC lifted its holdings in Henry Schein by 5.4% during the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after buying an additional 71,560 shares in the last quarter. Nuance Investments LLC boosted its holdings in Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after acquiring an additional 414,748 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in Henry Schein during the 3rd quarter worth about $515,000. Olstein Capital Management L.P. lifted its position in Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock valued at $7,543,000 after purchasing an additional 16,000 shares during the period. Finally, Equitable Trust Co. bought a new position in shares of Henry Schein in the 4th quarter valued at about $417,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.